200086257
Novus Biologicals™ Clostridium Difficile Toxin A Antibody (actoxumab), Novus Biologicals™
Human Monoclonal Antibody
Manufacturer: Fischer Scientific
The price for this product is unavailable. Please request a quote
Antigen
Clostridium Difficile Toxin A
Applications
Flow Cytometry, ELISA, Functional Assay
Conjugate
Unconjugated
Host Species
Human
Target Species
Human
Gene Alias
tcdA, toxA
Isotype
IgG1
Purification Method
Protein A purified
Content And Storage
Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone
actoxumab
Classification
Monoclonal
Form
Purified
Regulatory Status
RUO
Formulation
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen
Cdiff Toxin A
Primary or Secondary
Primary
Reconstitution
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Description
- Clostridium Difficile Toxin A Monoclonal antibody specifically detects Clostridium Difficile Toxin A in Human samples
- It is validated for Flow Cytometry,ELISA,Functional Assay
Compare Similar Items
Show Difference
Antigen: Clostridium Difficile Toxin A
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Target Species: Human
Gene Alias: tcdA, toxA
Isotype: IgG1
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone: actoxumab
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen: Cdiff Toxin A
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Antigen:
Clostridium Difficile Toxin A
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Target Species:
Human
Gene Alias:
tcdA, toxA
Isotype:
IgG1
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone:
actoxumab
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen:
Cdiff Toxin A
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Antigen: Proprotein Convertase 9/PCSK9
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Target Species: Human
Gene Alias: EC 3.4.21, EC 3.4.21.111, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Isotype: IgG4
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone: frovocimab
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen: PCSK9
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Antigen:
Proprotein Convertase 9/PCSK9
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Target Species:
Human
Gene Alias:
EC 3.4.21, EC 3.4.21.111, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Isotype:
IgG4
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone:
frovocimab
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen:
PCSK9
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Antigen: Proprotein Convertase 9/PCSK9
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Target Species: Human
Gene Alias: EC 3.4.21, EC 3.4.21.111, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Isotype: IgG4
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone: frovocimab
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen: PCSK9
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Antigen:
Proprotein Convertase 9/PCSK9
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Target Species:
Human
Gene Alias:
EC 3.4.21, EC 3.4.21.111, FH3neural apoptosis regulated convertase 1, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Isotype:
IgG4
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone:
frovocimab
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen:
PCSK9
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Antigen: TGF-beta 1
Applications: Flow Cytometry, ELISA, Functional Assay
Conjugate: Unconjugated
Host Species: Human
Target Species: Human
Gene Alias: CEDLAP, DPD1, latency-associated peptide, TGF beta, TGFB, TGFbeta, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1
Isotype: IgG4
Purification Method: Protein A purified
Content And Storage: Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone: fresolimumab
Classification: Monoclonal
Form: Purified
Regulatory Status: RUO
Formulation: Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen: TGFb1
Primary or Secondary: Primary
Reconstitution: Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.
Antigen:
TGF-beta 1
Applications:
Flow Cytometry, ELISA, Functional Assay
Conjugate:
Unconjugated
Host Species:
Human
Target Species:
Human
Gene Alias:
CEDLAP, DPD1, latency-associated peptide, TGF beta, TGFB, TGFbeta, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1
Isotype:
IgG4
Purification Method:
Protein A purified
Content And Storage:
Store at -20°C in powder form. Store at -80°C once reconstituted.
Clone:
fresolimumab
Classification:
Monoclonal
Form:
Purified
Regulatory Status:
RUO
Formulation:
Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Immunogen:
TGFb1
Primary or Secondary:
Primary
Reconstitution:
Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex.